The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
Abstract
Changes in health policy have underlined the importance of evidence-based clinical practice and rigorous evaluation of patient-based outcomes. As patient-based outcome measurement is particularly important in treatment trials of multiple sclerosis, a number of disease-specific instruments have been developed recently. One limitation of these instruments is that none was developed using the standard psychometric approach of reducing a large item pool generated from people with multiple sclerosis. Consequently, an outcome measure for clinical trials of multiple sclerosis that is disease specific and combines patient perspective with rigorous psychometric methods will complement existing instruments. The aim of this study was to develop such a measure. Standard psychometric methods were used. A pool of 129 questionnaire items was generated from interviews with 30 people with multiple sclerosis, expert opinion and literature review. The questionnaire was administered by postal survey to 1530 people selected randomly from the Multiple Sclerosis Society membership database. Redundant items and those with limited measurement properties were removed. The remaining items (n = 41) were grouped into scales using factor analysis, and then refined to form the Multiple Sclerosis Impact Scale (MSIS-29), an instrument measuring the physical (20 items) and psychological (nine items) impact of multiple sclerosis. Five psychometric properties of the MSIS-29 (data quality, scaling assumptions, acceptability, reliability and validity) were examined in a separate postal survey of 1250 Multiple Sclerosis Society members. A preliminary responsiveness study of the MSIS-29 was undertaken in 55 people admitted for rehabilitation and intravenous steroid treatment of relapses. The MSIS-29 satisfied all psychometric criteria. Data quality was excellent, missing data were low (maximum 3.9%), item test–re-test reliability was high (r = 0.65–0.90) and scale scores could be generated for >98% of respondents. Item descriptive statistics, item convergent and discriminant validity, and factor analysis indicated that it was legitimate to generate scores for MSIS-29 scales by summing items. MSIS-29 scales showed good variability, small floor and ceiling effects, high internal consistency (Cronbach's alpha ≤0.91) and high test–re-test reliability (intraclass correlation ≤0.87). Correlations with other measures and the analysis of group differences provided evidence that the MSIS-29 measures the physical and psychological impact of multiple sclerosis. Effect sizes (physical scale = 0.82, psychological scale = 0.66) demonstrated preliminary evidence of good responsiveness. These results indicate the MSIS-29 is a clinically useful and scientifically sound patient-based outcome measure of the impact of multiple sclerosis suitable for clinical trials and epidemiological studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coefficient Alpha and the Internal Structure of Tests
Cronbach, L. J. (1951) · Psychometrika · doi:10.1007/bf02310555 · Cited by 43,931
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
The Scree Test For The Number Of Factors
Cattell, R. B. (1966) · Multivariate Behavioral Research · doi:10.1207/s15327906mbr0102_10 · Cited by 13,554
Construct validity in psychological tests.
Cronbach, L. J., & Meehl, P. E. (1955) · Psychological Bulletin · doi:10.1037/h0040957 · Cited by 11,195
Health Measurement Scales: A Practical Guide to Their Development and Use
Streiner, D. L., Norman, G. R., & Cairney, J. (1989) · Cited by 9,595
Statistical Theories of Mental Test Scores
Rozeboom, W. W., Lord, F. M., Novick, M. R., & Birnbaum, A. (1969) · American Educational Research Journal · doi:10.2307/1162101 · Cited by 8,022
Probabilistic Models for Some Intelligence and Attainment Tests
(1961) · Information and Control · doi:10.1016/s0019-9958(61)80061-2 · Cited by 6,939
A scaled version of the General Health Questionnaire
Goldberg, D. P., & Hillier, V. F. (1979) · Psychological Medicine · doi:10.1017/s0033291700021644 · Cited by 5,459
Mail and Telephone Surveys: The Total Design Method.
Osmond, M. W., & Dillman, D. A. (1979) · Social Forces · doi:10.2307/2577403 · Cited by 5,023
Cited by
Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000156155.19270.f8 · Cited by 963
Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12)
Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003) · Neurology · doi:10.1212/wnl.60.1.31 · Cited by 821
Self-citationPrimary-progressive multiple sclerosis
Miller, D. H., & Leary, S. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70243-0 · Cited by 818
Smith, S., Lamping, D., Banerjee, S., Harwood, R., Foley, B., Smith, P., Cook, J., Murray, J., Prince, M., Levin, E., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9100 · Cited by 639
Hobart, J., & Cano, S. (2009) · Health Technology Assessment · doi:10.3310/hta13120 · Cited by 621
Self-citationChataway, J., Schuerer, N., Alsanousi, A., Chan, D., MacManus, D., Hunter, K., Anderson, V., Bangham, C. R. M., Clegg, S., Nielsen, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62242-4 · Cited by 443
Physical activity and autoimmune diseases: Get moving and manage the disease
Sharif, K., Watad, A., Bragazzi, N. L., Lichtbroun, M., Amital, H., & Shoenfeld, Y. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.010 · Cited by 324
Gold, R., Giovannoni, G., Selmaj, K., Havrdova, E., Montalban, X., Radue, E.-W., Stefoski, D., Robinson, R., Riester, K., Rana, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62190-4 · Cited by 287
Multidisciplinary rehabilitation for adults with multiple sclerosis
Khan, F., Turner-Stokes, L., Ng, L., Kilpatrick, T., & Amatya, B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006036.pub2 · Cited by 286
Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J.-P., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006168 · Cited by 281
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
Zajicek, J. P., Hobart, J. C., Slade, A., Barnes, D., Mattison, P. G., & on behalf of the MUSEC Research Group (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302468 · Cited by 278
Self-citationPsychological interventions for multiple sclerosis.
Thomas, P. W., Thomas, S., Hillier, C., Galvin, K., & Baker, R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004431.pub2 · Cited by 271
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Kappos, L., Wiendl, H., Selmaj, K., Arnold, D. L., Havrdova, E., Boyko, A., Kaufman, M., Rose, J., Greenberg, S., Sweetser, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501481 · Cited by 265
Martinez-Martin, P., Rodriguez-Blazquez, C., Abe, K., Bhattacharyya, K. B., Bloem, B. R., Carod-Artal, F. J., Prakash, R., Esselink, R. A. J., Falup-Pecurariu, C., Gallardo, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c0d416 · Cited by 262
Martinez-Martin, P., Rodriguez-Blazquez, C., Alvarez-Sanchez, M., Arakaki, T., Bergareche-Yarza, A., Chade, A., Garretto, N., Gershanik, O., Kurtis, M. M., Martinez-Castrillo, J. C., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6624-1 · Cited by 252
Cohen, J. A., Reingold, S. C., Polman, C. H., & Wolinsky, J. S. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70059-5 · Cited by 233
Baert, I., Freeman, J., Smedal, T., Dalgas, U., Romberg, A., Kalron, A., Conyers, H., Elorriaga, I., Gebara, B., Gumse, J., et al. (2014) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968314521010 · Cited by 213
Jones, K. H., Ford, D. V., Jones, P. A., John, A., Middleton, R. M., Lockhart-Jones, H., Osborne, L. A., & Noble, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041910 · Cited by 190
Distress improves after mindfulness training for progressive MS: a pilot randomised trial
Bogosian, A., Chadwick, P., Windgassen, S., Norton, S., McCrone, P., Mosweu, I., Silber, E., & Moss-Morris, R. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515576261 · Cited by 135
Dlugonski, D., Motl, R. W., Mohr, D. C., & Sandroff, B. M. (2012) · Psychology, Health & Medicine · doi:10.1080/13548506.2011.652640 · Cited by 133
Aragona, M., Onesti, E., Tomassini, V., Conte, A., Gupta, S., Gilio, F., Pantano, P., Pozzilli, C., & Inghilleri, M. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181633497 · Cited by 109
Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple Sclerosis
Levinthal, D. J., Rahman, A., Nusrat, S., O’Leary, M., Heyman, R., & Bielefeldt, K. (2013) · Multiple Sclerosis International · doi:10.1155/2013/319201 · Cited by 93
Wilski, M., Gabryelski, J., Brola, W., & Tomasz, T. (2019) · Disability and health journal · doi:10.1016/j.dhjo.2019.06.003 · Cited by 78
Non-pharmacological interventions for chronic pain in multiple sclerosis
Amatya, B., Young, J., & Khan, F. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012622.pub2 · Cited by 78
Lincoln, N. B., Yuill, F., Holmes, J., Drummond, A. E., Constantinescu, C. S., Armstrong, S., & Phillips, C. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511408753 · Cited by 73
Jones, K. H., Jones, P. A., Middleton, R. M., Ford, D. V., Tuite-Dalton, K., Lockhart-Jones, H., Peng, J., Lyons, R. A., John, A., & Noble, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104604 · Cited by 69
Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
Giordano, A., Pucci, E., Naldi, P., Mendozzi, L., Milanese, C., Tronci, F., Leone, M., Mascoli, N., La Mantia, L., Giuliani, G., et al. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.171181 · Cited by 54
Forman, A., & Lincoln, N. (2010) · Clinical Rehabilitation · doi:10.1177/0269215509343492 · Cited by 54
Wilkinson, H. R., & Nair, R. D. (2013) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2013.9.4.172 · Cited by 38
Brola, W., Sobolewski, P., Fudala, M., Flaga, S., Jantarski, K., Ryglewicz, D., & Potemkowski, A. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s109520 · Cited by 35
Learmonth, Y. C., Hubbard, E. A., McAuley, E., & Motl, R. W. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0639-2 · Cited by 28
Proctor, B. J., Moghaddam, N. G., Evangelou, N., & das Nair, R. (2018) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2018.07.006 · Cited by 26
Sesel, A.-L., Sharpe, L., Beadnall, H. N., Barnett, M. H., Szabo, M., & Naismith, S. L. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211068002 · Cited by 22
Wynia, K., Middel, B., de Ruiter, H., van Dijk, J. P., Lok, W. S., de Keyser, J. H. A., & Reijneveld, S. A. (2009) · Disability and Rehabilitation · doi:10.1080/09638280802509488 · Cited by 20
Lowe, R., Barlow, C., Lloyd, B., Latchem-Hastings, J., Poile, V., Scoble, C., Dean-Young, A., Button, K., Playle, R., & Busse, M. (2021) · Trials · doi:10.1186/s13063-021-05245-1 · Cited by 19
Multiple sclerosis: patient-reported quality of life in the Świętokrzyskie region
Brola, W., Sobolewski, P., Fudala, M., Flaga, S., & Jantarski, K. (2017) · Medical Studies · doi:10.5114/ms.2017.70345 · Cited by 12
Foshati, S., Poursadeghfard, M., Heidari, Z., & Amani, R. (2023) · Food & Function · doi:10.1039/d3fo00167a · Cited by 12
Foote, H., Bowen, A., Cotterill, S., Hill, G., Pieri, M., & Patchwood, E. (2023) · Clinical Rehabilitation · doi:10.1177/02692155221144554 · Cited by 7
Angelova, G., Skodova, T., Prokopiusova, T., Markova, M., Hruskova, N., Prochazkova, M., Pavlikova, M., Spanhelova, S., Stetkarova, I., Bicikova, M., et al. (2020) · Life · doi:10.3390/life10110267 · Cited by 6
Metadata
- Authors
- Hobart, J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05-01
- Volume
- 124
- Issue
- 5
- Pages
- 962-973
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2126737632
- Cited by
- 1,120
- References
- 41
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.